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The interest in biodegradable polymer-matrix nanocomposites with bone regeneration potential has
been increasing in recent years. In the present work, a solvothermal process is introduced to prepare
hydroxyapatite (HA) nanorod-reinforced polycaprolactone in-situ. A non-aqueous polymer solution
containing calcium and phosphorous precursors is prepared and processed in a closed autoclave at
different temperatures in the range of 60e150 C. Hydroxyapatite nanorods with varying aspect ratios
are formed depending on the processing temperature. X-ray diffraction analysis and field-emission
scanning electron microscopy indicate that the HA nanorods are semi-crystalline. Energy-dispersive X-
ray spectroscopy and Fourier transform infrared spectrometry determine that the ratio of calcium to
phosphorous increases as the processing temperature increases. To evaluate the effect of in-situ pro-
cessing on the mechanical properties of the nanocomposites, highly porous scaffolds (>90%) containing
HA nanorods are prepared by employing freeze drying and salt leaching techniques. It is shown that the
elastic modulus and strength of the nanocomposites prepared by the in-situmethod is superior (~15%) to
those of the ex-situ samples (blended HA nanorods with the polymer solution). The enhanced bone
regeneration potential of the nanocomposites is shown via an in vitro bioactivity assay in a saturated
simulated body fluid. An improved cell viability and proliferation is also shown by employing (3-(4,5-
dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide) (MTT) assay in human osteosarcoma cell lines.
The prepared scaffolds with in vitro regeneration capacity could be potentially useful for orthopaedic
applications and maxillofacial surgery.
© 2017 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
Tissue engineering offers a new approach to regenerate diseased
or damaged tissues such as bone [1]. The rapidly growing research
in the bone tissue engineering area provides a new and promising
approach for bone repair and regeneration [2]. Bone is a natural
organiceinorganic composite consisting of collagen fibrils con-
taining embedded, well-arrayed, nanocrystalline and plate-like
inorganic materials with length of 25e50 nm [3,4]. Hydroxyapa-
tite (HA), which is chemically similar to the inorganic component ofience and Engineering, Sharif
nications Co., Ltd.
ing by Elsevier B.V. on behalf of Ke
d/4.0/).bonematrix, has been proved to be an osteoconductive material [5]
with affinity toward many adhesive proteins and direct involve-
ment in the bone cell differentiation and mineralization processes
[6]. The close chemical similarity of HA to natural bone has led to
extensive research efforts to use synthetic HA as a bone substitute
and/or replacement in biomedical applications [7]. However, HA
shows poor biomechanical properties such as high brittleness as
well as low fatigue strength and flexibility that limit its load-
bearing applications [8]. As a result, synthesis of HA particles
with various sizes and morphologies and distribution of them in-
side biodegradable polymer matrixes have attracted significant
interest in recent years [9]. The idea of combining bioactive ce-
ramics and degradable polymers to produce three-dimensional
(3D) scaffolds with high porosity is a promising strategy for the
design and development of composite systems for bone tissueAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND
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either by distributing HA nanoparticles within a polymer matrix or
by the mineralization of HA nanoparticles on the surface of poly-
meric substrates [10e13]. Much work has also been performed on
the processing and applications of HA nanorods for bone tissue
engineering as the bioactivity and mechanical properties are
significantly enhanced compared to irregular-shaped particles
[14e18].
In the present work, polycaprolactone (PCL) nanocomposites
containing HA nanorods were prepared by in-situ solvothermal
techniques. Polycaprolactone is a biodegradable polymer with
remarkable toughness and good biocompatibility [19]. It is a semi-
crystalline aliphatic polymer that has a slower degradation rate and
higher fracture energy thanmost biocompatible polymers [20e23].
The intrinsic hydrophobic chemical nature of PCL as well as its poor
surface wetting and interactions with biological fluids avoid cell
adhesion and proliferation [11]. It has recently been shown that the
biological and mechanical properties of PCL scaffolds can be
tailored by osteogenic and osteoinductive inorganic phases, pro-
moting bone regeneration [24e27]. Chen el al. [28] observed that
relative cell survival of PCL-HA composites exceeded that of neat
PCL and control samples in MTT assay. Nevertheless, poor interfa-
cial adhesion is often observed when HA particles are ex-situ
dispersed in a polymer matrix (due to different chemical nature of
the components and their surface energy). Consequently, the ex-
situ prepared composites may exhibit degraded mechanical prop-
erties. Li et al. [29] reported that surface treatment of HA nano-
particles by a kind of silane (ɤ-glycioxypropyltrimethoxysilane),
aiming to improve mechanical properties of PCL-HA composite, led
to relative aggravation in biocompatibility and bioactivity
(although the resulted values still exceeded that of control sample).
A promising strategy to improve the distribution of the bioceramic
in the polymer matrix with higher degree of phase interaction
between the polymer and the inorganic filler is to synthesize the
HA nanoparticles in-situ during processing of the scaffolds [11,30].
This procedure would avoid the extensive particle agglomeration
typically seen in composites obtained by mechanical incorporation
of HA particles into the polymer melt or solution [11]. Recently, co-
precipitation and sol-gel methods have been utilized to synthesize
HA nanoparticles-reinforced PCL nanocomposites [30e32]. Owing
to the superior properties of HA nanorods, a few attempts have also
made on processing of poly (D, L-lactide) (PDLLA) and polyvinyl
alcohol (PVA) composites by employing solvothermal processes
[33,34]. While the former polymer is expensive, the latter has weak
mechanical characteristics. Therefore, we have adopted a new
strategy for in-situ preparation of HA nanorods in the PCL matrix
with fine particle distribution. Polycaprolactone is a FDA approved
polymer which is relatively cheap with reliable mechanical
strength [10,11,21]. Highly porous scaffolds (>90%) were prepared
by salt leaching/freeze-drying techniques and their physicochem-
ical, biological and mechanical properties were examined. The
potential and benefits of the in-situ solvothermal processing
compared to the ex-situ method is shown.
2. Experimental
2.1. Materials
Calcium hydrate (Ca(OH)2, Acros, USA) and phosphoric acid (85%
H3PO4, Merck, Germany) were used as Ca and P precursors for the
synthesis of PCL/HA nanocomposites. Polycaprolactone with an
averagemolecular weight of 80,000 was supplied by Sigma-Aldrich
(USA). Analytical grades of acetone (Merck), dimethyl carbonate
(DMC, Merck) and tetrahydrofuran (THF, Merck, Germany) were
utilized as solvent. Ammonia (25%, Merck) was used to adjust thepH. Hydroxyapatite powder with an average size of 60 nm was
supplied by Merck (Germany). Sodium chloride crystals with sizes
of 200e400 mmwere provided by Merck (Germany) and utilized as
porogen.2.2. In-situ solvothermal process
Four grams of PCL was dissolved into 40 ml acetone under
vigorous stirring for 6 h using a magnetic stirrer. The calcium
precursor was added into the solution and mixed for 6 h. In a
separate beaker, H3PO4 was added to acetone andmixed vigorously
for 6 h. This solution was added to the PCL solution dropwise to
achieve a Ca:P molar ratio of 1.67. The concentration of HA particles
in the polymer matrix was set to 20 wt%. The HA concentrationwas
selected based on the results of Rezaei et al. [30] that showed the
highest tensile strength could be attained in PCL-20%HA nano-
composites. Ammonia was used to control the pH of the final sol to
~10. This sol was transferred to a sealed autoclave and stirred
vigorously for 24 h at different temperatures ranging from 60 to
150 C. It is pertinent to point out that, some studies have reported
that PCL can react with ammonia at temperatures roughly above
200 C [35,36]; hence, the chemical nature of PCL is not affected in
the examined range. The prepared PCL/HA nanocomposite was
poured into a Petri dish and dried for 24 h at room temperature.2.3. Fabrication of porous scaffolds
To prepare PCL/HA scaffolds, the nanocomposite film was dis-
solved in DMC under vigorous stirring for 8 h using a magnetic
stirrer. To create open and large pores, sodium chloride crystals
were added to the polymeric solution (30 vol%) and stirred for 2 h.
The mixture was then poured into cylindrical aluminium moulds
(1 cm diameter and 1.5 cm height) and freeze-dried for
24 h at 70 C and 0.01 mbar. Afterwards, the scaffolds were
immersed in double-distilled water for 7 days to remove the salt
and extra ions formed during the solvothermal synthesis. To pre-
pare ex-situ PCL/HA nanocomposite, the commercial HA powder
and NaCl crystals were added to the polymeric solution and ho-
mogenized by stirring for 2 h. Freeze-drying and salt leaching
techniques were utilized to prepare highly porous scaffolds (>90%
porosity).2.4. Materials characterization
To analyse the in-situ processed HA particles in the polymer
matrix, the nanocomposite was dissolved in THF and centrifuged at
3000 rpm for 30 min. The extracted powder was dried and
weighted. Morphological analysis was performed on HA and PCL/
HA nanocomposites using a MIRA k TESCAN (Czech Republic) and a
HITACHI S4160 field-emission scanning electron microscope (FE-
SEM, Japan). Phase analysis was conducted using a STOE STADI P X-
ray diffractometer (XRD, Germany). Fourier transform infrared
(FTIR) spectroscopy (SHIMADZU, Japan) was used to identify the
functional groups of HA and to determine the bonds between the
ceramic and polymer phases in the composite material. FTIR
spectrum was recorded in the range of 500e4000 cm1 with a
resolution of 4 cm1. To determine the hydrophilicity of the pre-
pared films, water contact angle was measured by an OCA15plus
video based optical contact angle meter (Dataphysics Instruments
GmbH, Filderstadt, Germany). An equal volume of deionized water
(4 ml) was placed on the film by means of an electronic syringe unit
forming a drop. Photos were taken to record the shape of the drops
and the images were analyzed using the instrument software.
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To determine the mechanical properties of the materials and
porous scaffolds, tensile and compression tests were utilized on
films and cylindrical specimens, respectively. Tensile testing was
performed on films with 0.3 mm thickness and a gauge length of
60 mm  10 mm. Five tensile tests were performed for each film by
employing a Hounsfield machine (H10KS, UK) at a cross-head
speed of 5 mm/min. For the compression test, cylindrical samples
with 15 mm height and 10 mm diameter were examined at a cross-
head speed of 1 mm/min. It should be noted that due to the self-
lubricating property of the polymer and its highly porous struc-
ture, the ratio of diameter to height does not significantly affect the
deformation process during upsetting of small samples. The me-
chanical characteristics of the scaffolds were determined based on
the method explained in Ref. [37] for analysing of polymer foams.
To evaluate the mechanical properties of the materials without the
effect of interconnected pores, dense cylindrical samples of both
pristine PCL and PCL/HA nanocomposite (15 mm height and 10 mm
diameter) were also prepared by compression moulding at 100 C/
1500 N and examined by the compression test. The average of the
mechanical strength with standard deviation was reported. The
confidence interval for the average was 90%.2.6. In vitro bioactivity
In vitro bioactivity of the nanocomposites was evaluated using
simulated body fluid (SBF) solution according to the procedure
reported in Refs. [38,39]. The composition and pH of the utilized
SBF solution are reported in Electronic Supplementary Information
(ESI). The scaffolds were soaked in the SBF solution for 7 and 14
days at 37 C in an incubator. The ratio of the scaffold surface to the
volume of SBF solution was 10 mm2/ml in accordance with
Ref. [40]. The formed precipitates on the surface of the scaffolds
were examined by FESEM equipped with a energy dispersive X-ray
(EDX) spectrometer (VEGA\TESCAN, 15.00 KV). Blue staining of the
incubated scaffolds in SBF was performed by a hydrophilic dye
utilizing a 0.5% trypan blue solution (w/v) in order to indicate the
presence of HA particles on the surface of the scaffolds [19]. After
rinsing with absolute ethanol, digital images of the specimens were
taken by a digital camera.2.7. Cell viability
Human osteosarcoma cells (The Pasteur Institute of Iran, Teh-
ran) were utilized for cell viability. It is noteworthy that osteoblast
or osteocyte cell line is appropriate to determine the cellular
behaviour of the synthesized materials for bone tissue engineering.
Since the aim of this study was to show that the materials were not
toxic to cells and osteosarcoma cell line was accessible, this cell line
was used. The cells were added to a 96-well culture plate at a
concentration of 5000 cells/well with 10% fetal bovine serum and
1% antibiotics (100 mg/ml of streptomycin and 100 U/ml of peni-
cillin), and incubated for 24 h. Small specimens (6 mg) were cut
from the porous scaffolds and placed in the culture plate after UV
sterilizing for 1 h. After 48 and 72 h incubation at 37 C in a 5% CO2
atmosphere, the cell viability were evaluated by adding 10 ml of (3-
(4,5- Dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide)
(MTT) solution. After 3 h incubation, unreacted dye was removed
by aspiration cautiously, and then 150 ml dimethyl sulfoxide was
added into each well and shacked for 10 min. The optical density
(OD) of the each solution was measured with ELIZA Reader at
wavelength of 530 nm and 630 nm. Each assay was repeated 5
times and the average values were reported.2.8. Statistics
One-way ANOVA (p < 0.05, n ¼ 5) was applied using Statistical
Package for the Social Sciences (SPSS software, Version 16, IBM,
USA) to examine the statistically significant difference between
measurements.
3. Results
3.1. Characterization of hydroxyapatite nanorods
A solvothermal process was employed to prepare PCL-based
nanocomposites reinforced with HA particles. Fig. 1 shows FE-
SEM images of the bioceramic nanoparticles obtained at different
processing temperatures. At 60 C, the particles with irregular
shapes are formed. The solvothermal treatment of the polymer/HA
precursors at 70 C yields rod-shape particles with a diameter of
~30 nm and a length of ~230 nm. Processing at higher temperatures
forms nanorods with higher diameters (width) and aspect ratios
(height to width). At 120 C, rods with a diameter of about 70 nm
with an aspect ratio of 7 are attained. The one-dimensional growth
of ceramic nanorods is commonly ascribed to the surface energy of
crystal planes as the absorption of cations and anions from the
solution varies with the plane surface energy [41,42]. In order to
determine the composition of the precipitates, EDS and XRD were
employed (Fig. 2). EDS analysis determines that the Ca/P ratio is in
the range of 1.6e1.7 (Table 1). It is also noticeable that the chemical
composition of the precipitates becomes closer to the stoichio-
metric Ca/P ratio of HA (1.67 [30]) as the processing temperature is
increased. The XRD pattern of the rods prepared at 80 C is well
matched with the standard (JCPDS 09e432) and commercial
(Merck) HA particles, although residual amounts of PCL is also
detectable after the separation process (at 2q ¼ 15.7, 21.5 and
23.8). The characteristic peaks of HA are relatively broad that is
induced by their small (crystallite) sizes and their semi-crystalline
nature [43]. According to the peak intensity ratio (I112/I300) [44], the
crystallinity of the particles is estimated to be 20%. The relatively
low processing temperature yields poorly crystalline HA particles,
which favours bone regeneration in vivo [30,45]. It is noteworthy
that bone regeneration could be weak in highly crystalline porous
HA ceramics [46]. Moreover, no characteristic peaks of calcium
carbonates are visible both in XRD analysis (with considering the
detection limit of XRD) and FTIR examination (see next section).
This observation reveals one of the advantages of the in-situ sol-
vothermal process compared to the most wet-chemical derived
hydroxyapatite especially solegel routs [30].
3.2. Polymer matrix nanocomposites
The FTIR spectrum of the PCL/nanorod-HA nanocomposite
prepared at 80 C is shown in 3a. Most corresponding bands of HA
and PCL materials are visible in the spectrum that confirms the
formation of both compounds in the nanocomposite. The C]O,
CeO, and C]H bands are related to PCL. The first indication of the
hydroxyapatite formation is the form of broad FTIR band cantered
at about 1000e1100 cm1 [47]. The bands at 960e965 cm1 and
565e600 cm1 correspond to n1 and n4 symmetric PeO stretching
vibration of the PO34 ion [48,49]. Moreover, the peaks at 1420 and
1460 cm1 are related to OH bonds in HA [28]. As compared to
pristine HA and PCL, small peak shift could indicate formation of
bonds between HA and PCL during the chemical process [30].
Fig. 3b and c shows SEM micrographs of the prepared scaffolds by
the salt leaching method. The SEM images indicate that the scaffold
has a porous structure with pore sizes in the range of 10e200 mm.
The effect of HA particles on the hydrophilicity of PCL films is
Fig. 1. FE-SEM micrographs of HA powder prepared by in-situ solvothermal process at different temperatures (C) of a) 60, b) 70, c) 80, d) 90, e) 120, and f) 150.
Fig. 2. EDS spectrum and XRD pattern of HA particles in-situ synthesized by solvothermal processing at 80 C. The XRD pattern of commercial HA powder (Merck) is included for
comparison.
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bicity of PCL matrix. The difference between the in-situ and ex-situ
particles is not conspicuous, though the surface roughness andsurface distribution of the particles could influence the contact
angle.
Table 1
Effect of processing temperature on the Ca/P ratio of the in-situ synthesized particles
as determined by EDS.
Temperature (C) 60 70 80 90
Ca/P atomic ratio 1.60 1.65 1.66 1.70
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Fig. 4a shows compressive stress-strain curves for the PCL and
in-situ PCL/HA(20 wt%) nanocomposite prepared by compression
moulding (without porosity). The curves are the average of five
examinations. The elastic modulus and strength of the materials
were determined by the procedure explained in Ref. [37]. The re-
sults are reported in Table 2. As seen, the presence of HA nanorods
increases the elastic modulus and strength by ca. 50% and 26%,
respectively. Fig. 4b shows the compression curves for highly
porous scaffolds (>90%) prepared by freeze-drying and salt leach-
ing processes (averaged over 5 samples). Under compression load,
all curves display the typical characteristics of porous polymeric
foams, in which a linear elastic region appears at low strain fol-
lowed by a long plateau region and finally a rapid increasing regionFig. 3. Characterization of PCL/nanorod-HA nanocomposite prepared by in-situ solvotherma
images of PCL/HA scaffolds prepared by the salt leaching method at two different magnifi
solvent casting methods.due to the material densification [13]. The effect of HA particles on
the mechanical strength is less pronounced than that of dense
specimens due to the role of open pores on the flow behaviour of
the polymer matrix under loading. Meanwhile, the in-situ pro-
cessed nanocomposite yields improvedmechanical performance as
compared to the ex-situ one. This enhancement can be attributed to
the morphological effect (nanorod versus spherical particles),
interfacial bonding between HA and PCL, and possibly better dis-
tribution of the nanoparticles in the polymer matrix during in-situ
processing [30e32]. Similar results are obtained under tensile
loading for films (Fig. 4c). The strength of the nanocomposite pre-
pared by the in-situ method is about 15% higher than the ex-situ
one (Table 2). Although the addition of HA nanoparticles is
accompanied with reduction of ductility, the detrimental effect of
the in-situ processed bioceramics is less than the ex-situ
nanocomposite.
3.4. Bioactivity
After immersion of PCL/HA(20%) scaffold in SBF for 14 days, SEM
and EDAX analyses were conducted. Fig. 5a shows that calcium
phosphate crystals cover the surface of the scaffold. Thel processing at 80 C. (a) FTIR spectrum as compared to pristine HA and PCL. (b,c) SEM
cations. (d) Effect of HA nanoparticles on the hydrophilicity of PCL films prepared by
Fig. 4. Engineering stress-strain curves for PCL and PCL/HA(20%) nanocomposites. (a) Compression curves of dense PCL and in-situ PCL/HA specimens prepared by compression
moulding. (b) Compression curves for PCL/HA porous scaffolds. (c) Tensile behaviour of PCL and PCL/HA nanocomposite films.
Table 2
Mechanical properties of PCL and PCL-20%HA nanocomposites.
Property (MPa) Test Sample PCL Ex-situ nanocomposite In-situ nanocomposite
Elastic modulus Compression Dense cylinder 160.8 ± 7 e 241.6 ± 12
Compression Porous scaffold e 1.39 ± 0.048 1.99 ± 0.076
Tensile Film 106 ± 6 117 ± 3 126 ± 4
Strength Compression Dense cylinder 15 ± 0.2 e 19 ± 0.4
Compression (in kPa) Porous scaffold e 114 ± 11 159 ± 7
Tensile Film 9.3 ± 0.3 10.7 ± 0.2 11.8 ± 0.2
e Not measured.
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scaffold as a result of the high concentration of SBF which induces a
fast and uniform deposition of hydroxyapatite on the nano-
composite scaffolds. The Ca/P ratio of the precipitates is approxi-
mately 1.67, revealing the formation of HA particles upon
immersion in SBF. Fig. 5b shows digital images of the nano-
composite scaffold treated by the trypan blue solution (0.5 w/v%).
The blue colour of the specimens indicates the presence of HA
particles on the surface of the scaffolds. It is noted that the blue
colour is intensified by immersion in SBF, particularly at prolonged
times.3.5. Cytotoxicity
Cell viability of PCL/HA(20%) nanocomposites was studied in
human osteosarcoma cell lines byMTTassay (Fig. 6). The composite
scaffolds exhibit higher cell viability than that of the control with an
improvement in the viability with the incubation time. Since the
increase in the viability is a direct measure of living cells [29], the
results suggest that cell proliferation has taken place. The higher
cell viability of the in-situ prepared PCL/HA scaffold compared to
the ex-situ scaffold can be attributed to the morphology and crys-
tallinity of the HA crystals [14,46].
Fig. 5. (a) SEM images and EDS spectrum of the in-situ synthesized PCL/HA nanocomposite after 14 days immersion in SBF. (b) Digital images of PCL/HA nanocomposite (A) before
and (BeD) after trypan blue treatment: The scaffolds (B) was treated before immersing in SBF while the others were after (C) 7 days and (D) 14 days immersion.
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In this work, HA nanorods were synthesized in alkaline condi-
tions in the presence of PCL through solvothermal methods. The
mechanism of the crystal formation is schematically shown in
Fig. 7a. The process includes two steps of nucleation and growth. In
the initial stages, nucleuses of HA are formed in the supersaturated
medium of Ca and P ions [50]. Afterwards, the nucleuses are grown
in the high-pressure vessel. It is demonstrated that temperature
and pH are the most significant factors affecting the structural and
morphological characteristics of HA nanoparticles [51]. The atomic
structure of the HA unit cell makes the interfacial free energy of the
(001) plane (perpendicular to the c-axis) greater than the otherfaces [52]. Therefore, at a high critical concentration of ions in the
bulk solution, directional growth occurs as the ions migrate to the
(001) face, causing the crystals to grow exclusively along the c-axis
of HA [53]. Increasing of the processing temperature affects the
kinetics of nucleation and growth. The effect of temperature on the
size and aspect ratio of the prepared HA particles are shown in
Fig. 7b. At higher temperatures, the number of nucleuses is
increased and at the same time the growth rate is enhanced due to
the faster diffusion rate [51]. The higher temperature also facilitates
the crystal growth as the role of surface tension on specific crystal
facets is reduced. As a result, both width and length of the crystals
increase with increasing the temperature. Nevertheless, at high
temperatures there is a counterbalance between rapid diffusion
Fig. 6. Cell viability of PCL/HA(20%) nanocomposites incubated in human osteosar-
coma cell lines. The statistically significant difference was determined by ANOVA,
P < 0.05, n ¼ 5.
Fig. 7. (a) Schematic presentation of nucleation and growth of HA particles in the
polymer matrix (PCL) during solvothermal processing in an alkaline solution (pH ¼ 10).
(b) Effect of temperature on the dimensions of in-situ synthesized HA particles.
S. Moeini et al. / Bioactive Materials 2 (2017) 146e155 153rate of ions and their saturation concentration in the solution [52].
In fact, high number of nucleuses along with their rapid growth
decreases the ion concentration into a level where the overall
chemical potential of the bulk solution decreases. This makes it
difficult for the diffusion flux of ions to preferentially go to the (001)
face of HA. It was also demonstrated that the prepared nano-
particles are stoichiometric HA with a low degree of crystallinity(Fig. 2). Previous studies have shown that crystalline HA particles
are commonly synthesized at temperatures >120 C [51], at which
the driving forces to order atoms and move them to the crystalline
sites are provided. It is thus suggestible that at relatively low pro-
cessing temperature (80 C), HA particles with a low crystallinity
are formed due to low driving force for the diffusion of atoms.
The mechanical properties of nanocomposites are influenced by
the uniform dispersion of filler into the matrix and good interfacial
bonding between them [1,2]. We employed in-situ solvothermal
processing to attain a more uniform dispersion of HA nanorods in
the PCL matrix, and possibly improved chemical bonding. Never-
theless, FTIR spectroscopy showed no strong chemical bonding
between HA and PCL. On the other hand, wemeasured an improved
mechanical strength for the in-situ processed composite compared
with the ex-situ one. Therefore, we concluded that the improved
strength could mainly be attributed to better distribution of the
filler in the polymermatrix. It was also observed that this effect was
less influenced for the porous scaffolds prepared by freeze drying
and salt leaching methods. This is because of high porosity content
of the scaffolds (>90%), which significantly affects the mechanical
strength of the nanocomposites.
In vitro bioactivity assay also showed that the in-situ processed
nanocomposite has higher activity in SBF than the ex-situ one. It is
known that HA particles act as heterogeneous nucleation sites for
the subsequent deposition of crystals from the solution whit a ki-
netics dependency on the morphology, surface area and crystal-
lography preference of the HA particles [14]. Since HA nanorods
with low crystallinity were synthesized, higher bioactivity
compared with the regular-shaped particles and highly crystalline
HA particles was attained. The low crystallinity of the HA nanorods,
which are thermodynamically less stable, provided higher dis-
solubility in the solution induced by solution-mediated dissolution
(rather than cellular/enzyme action) [54e56]. In other words, the
dissolved ions facilitated nucleation and growth of subsequent
natural/biological HA. On the other hand, cell viability assay
showed that the prepared scaffolds are not cytotoxic. Both com-
posites exhibited better response to the cells compared to the
control one. Probably the HA particles provided a surface suitable
for cell attachment and proliferation [57] along with the presence
of large pores (100e200 mm) which promote proliferation of cells
[30]. A higher cell proliferation on the in-situ rod-like HA-PCL
nanocomposite compared to the ex-situ one can be attributed to
the effect of HA morphology and its low crystallinity [58]. Black-
wood and Seah [59] have reported that HA nanorods have a better
influence on the cell proliferation and bioactivity. On the other
hand, Xu et al. [60] also have shown that spherical nanoparticles
(mean diameter of 20 nm) induced higher expressions of metabolic
enzymes, which suggest that spherical nanoparticles might be
more potentially hazardous to the osteoblasts as compared to the
nanorods.
5. Conclusions
A solvothermal process was employed to prepare nanorod
HA(20%)-reinforced PCL composite scaffolds. It was shown that the
aspect ratio of the HA nanorods was increased from 2 to 10 by
increasing the processing temperature from 70 to 150 C. Pro-
cessing at 80 C was found to be suitable to attain low crystalline
HA nanorods with an aspect ratio of about 4 without severe
agglomeration in the PCL matrix. The prepared nanocomposite
exhibited better bioactivity in SBF than the ex-situ prepared PCL/
HA nanocomposite through mixing of the constituents. The me-
chanical strength was also higher. The in vitro cellular assays sug-
gested the scaffolds of nanorod-HA/PCL and HA/PCL were nontoxic
to human osteosarcoma cell. Therefore, the prepared scaffolds
S. Moeini et al. / Bioactive Materials 2 (2017) 146e155154could be promising for non-load bearing bone regeneration
because of their good mechanical properties and ability to promote
apatite growth.
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